Delivery Order SPE2DR25D3010-SPE2DR26F88DE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,079.54 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity. The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of December 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $4,737.30, with completion scheduled for December 1, 2025. This non-competitive delivery order represents a pharmaceutical procurement supporting federal medical supply needs, with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,265.11 on November 14, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $55,533.83. This firm fixed-price delivery order, which is expected to be completed by November 26, 2025, represents a non-competitive set-aside procurement supporting federal pharmaceutical supply needs. The contract is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This competitively awarded contract, valued at $34,528.08, represents a firm fixed-price delivery order with performance completion scheduled for August 28, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a contract value of $39,828.37. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025. The contract was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. As a child order, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Jardiance 10 mg tablets in a 90-count package, with a contract ceiling value of $10,123.57. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88DEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price arrangement. The contract carries a ceiling value of $9,617.27 and is scheduled for completion by December 4, 2025. This is a non-set-aside, competitively awarded delivery order that leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad range of pharmaceutical products, medications, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Jardiance, a diabetes medication, exemplifies the company's role in supplying essential pharmaceutical commodities to support Defense Health Agency operations and other government healthcare systems through flexible and comprehensive contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 12/2/25 |